Author(s):
Sachin Panchal, Hindustan Abdul Ahad, Harshitha Srinivas, Gaanavi B. Ramachandra, Monish Gangadharaiah, Sunidhi Srinivas
Email(s):
andulhindustan@gmail.com
DOI:
10.52711/0975-4377.2024.00039
Address:
Sachin Panchal, Hindustan Abdul Ahad, Harshitha Srinivas, Gaanavi B. Ramachandra, Monish Gangadharaiah, Sunidhi Srinivas
Department of Pharmaceutics, RR College of Pharmacy, Chikkabanavara, Bangalore - 90, Karnataka India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 3,
Year - 2024
ABSTRACT:
Ocular drug delivery poses significant challenges in maintaining therapeutic drug levels at the targeted site for an extended period. Traditional ocular medications, such as eye drops, often necessitate frequent administration and may lead to issues like corneal crystalline deposits. In response to these challenges, novel formulations like ocular inserts have emerged. Ocular inserts are specialized drug delivery systems designed for ophthalmic application, offering controlled release, and prolonged drug activity. This review explores the benefits of ocular inserts over conventional dosage forms, highlighting their ability to enhance ocular residence time and bioavailability through slow, constant drug release. Additionally, the review covers the physiology of the eye and various preparation and evaluation methods of ocular inserts, providing insights into their potential as effective alternatives in ocular drug delivery.
Cite this article:
Sachin Panchal, Hindustan Abdul Ahad, Harshitha Srinivas, Gaanavi B. Ramachandra, Monish Gangadharaiah, Sunidhi Srinivas. Breaking Barriers in Ocular Drug Delivery: Unveiling the Role of Ocular Inserts as Controlled Release Systems. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(3):245-0. doi: 10.52711/0975-4377.2024.00039
Cite(Electronic):
Sachin Panchal, Hindustan Abdul Ahad, Harshitha Srinivas, Gaanavi B. Ramachandra, Monish Gangadharaiah, Sunidhi Srinivas. Breaking Barriers in Ocular Drug Delivery: Unveiling the Role of Ocular Inserts as Controlled Release Systems. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(3):245-0. doi: 10.52711/0975-4377.2024.00039 Available on: https://rjpdft.com/AbstractView.aspx?PID=2024-16-3-8
REFERENCES:
1. Kumari A, Sharma PK, Garg VK, Garg G. Ocular inserts—Advancement in therapy of eye diseases. Journal of Advanced Pharmaceutical Technology & Research. 2010;1(3):291-6.
2. Rathore K, Nema R. Review on ocular inserts. Int J PharmTech Res. 2009;1(2):164-9.
3. Aburahma MH, Mahmoud AA. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation. Aaps Pharmscitech. 2011;12:1335-47.
4. Sahane N, Banarjee S, Gaikwad D, Jadhav S, Throat R. Ocular inserts: a review. Drug Inven Tod. 2010;2:57-64.
5. Karthikeyan D, Bhowmick M, Pandey VP, Nandhakumar J, Sengottuvelu S, Sonkar S, et al. The concept of ocular inserts as drug delivery systems: An overview. Asian Journal of Pharmaceutics. 2008;2(4).
6. Banu S, Farheen SA. Ocular Drug Delivery System: A Novel Approach. Asian Journal of Research in Pharmaceutical Science. 2019; 9(2):97-106.
7. Parmar RB, Tank H. Design formulation and evaluation of reservoir type controlled released moxifloxacin hydrochloride ocular insert. Asian Journal of Research in Pharmaceutical Science. 2013;3(1):19-24.
8. Vasanani MR, Patel N, Patel D, Rajesh K, Jha LL. Mucoadhesive-nanoparticulate system for ocular delivery of loteprednol etabonate. Asian Journal of Pharmaceutical Research. 2014; 4(2): 78-83.
9. Eltahir AKAE, Ahad HA, Haranath C, Meharajunnisa B, Dheeraj S, Sai BN. Novel Phytosomes as Drug Delivery Systems and its Past Decade Trials. 2023.
10. Sailaja K, Hindustan AA, Chinthaginjala H, Gudisipalli R, Sugali RI, Vagganagari Y. Approaches to creating and past successful attempts on microspheres: A primer for aspiring researchers. 2022.
11. Reddy DM, Reddy YK, Reddy DR, Kumar NV, Suresh M, Althaff M, et al. Formulation and evaluation of ciprofloxacin ocuserts. Research Journal of Pharmacy and Technology. 2011; 4(11): 1663-5.
12. Sai BN, Ahad HA, Chinthaginjala H, Meharajunnisa B, Siriguppa D, Mallem VB. Human organic cation transporter use and drug target responses. 2023.
13. Fouziya B, Hindustan AA, Dontha SC, Jagarlamudi SV, Reddy UC, Reddy PN. Fabrication and evaluation of cefpodoxime proxetil niosomes. Asian Journal of Pharmacy and Technology. 2022; 12(2): 109-12.
14. Ahad HA, Chinthaginjala H, Rahamtulla S, Pallavi BP, Shashanka C, Prathyusha J. A comprehensive report on solid dispersions by factorial design. 2021.
15. Mamatha D, Ahad HA, Ushasree G, Vinod K, Haranath C, Kiran P. Out-of-Trend Statistics in The Pharmaceutical Industry: A Gain Leap in Assuring the Quality of The product. Asian Journal of Research in Chemistry. 2023; 16(6): 423-8.
16. Ahad HA, Haranath C, Kumar BP, Roy D, Dharani BHS, Ayisha MU. A desk top allusion to the rare orphan diseases and orphan drugs: possessions to discern by every healthcare professional. 2021.
17. Abdul AH, Bala AG, Chintaginjala H, Manchikanti SP, Kamsali AK, Dasari RRD. Equator assessment of nanoparticles using the design-expert software. International Journal of Pharmaceutical Sciences and Nanotechnology. 2020;13(1):4766-72.
18. Ahad HA, Haranath C, Tarun K, Krishna JV, Chandana N, Indrani B. Immuno-boosters as health accelerants to tackle viral infections. Asian Journal of Pharmaceutical Research. 2021;11(3):212-6.
19. Abdul Ahad H, Sreeramulu J, Padmaja BS, Reddy MN, Prakash PG. Preparation of Fluconazole International Scholarly Research Notices. 2011;2011.
20. Jyothika LSK, Ahad HA, Haranath C, Kousar S, Sadiya SH. Types of transdermal drug delivery systems: a literature report of the past decade. 2022.
21. Jervis L. A summary of recent advances in ocular inserts and implants. J Bioequiv Bioavailab. 2017;9:320-3.
22. Sultana Y, Aqil M, Ali A. Ocular inserts for controlled delivery of pefloxacin mesylate: Preparation and evaluation. Acta Pharmaceutica. 2005;55(3):305-14.
23. Mishra D, Gilhotra R. Design and characterization of bioadhesive in-situ gelling ocular inserts of gatifloxacin sesquihydrate. DARU Journal of Pharmaceutical Sciences. 2008;16(1):1-8.
24. Ahad HA, Kumar GA, Chinthaginjala H, Gnaneswar P, Baba HA, Krishna A. A Quick Reference to the Decade’s Literature Reviewed on Ocular Films. Journal of Young Pharmacists. 2022; 15(1): 49-54.
25. Roja Y, Ahad HA, Chinthaginjala H, Soumya M, Muskan S. A Glance at the Literature review on Buccal films. 2022.
26. De Souza JF, Maia KN, Patrício PSDO, Fernandes-Cunha GM, Da Silva MG, Jensen CEDM, et al. Ocular inserts based on chitosan and brimonidine tartrate: Development, characterization and biocompatibility. Journal of Drug Delivery Science and Technology. 2016; 32: 21-30.
27. Khurana G, Arora S, Pawar PK. Ocular insert for sustained delivery of gatifloxacin sesquihydrate: Preparation and evaluations. International Journal of Pharmaceutical Investigation. 2012; 2(2): 70.
28. Babu GN, Menaka M, Ahad HA, Veerabomma S. In Vivo Pharmacokinetic Studies of Acyclovir Gastro Retentive Mucoadhesive Microspheres Aided by Azadirachta indica Fruit Mucilage. Research Journal of Pharmacy and Technology. 2023; 16(10): 4554-8.
29. Balguri SP, Adelli GR, Tatke A, Janga KY, Bhagav P, Majumdar S. Melt-cast noninvasive ocular inserts for posterior segment drug delivery. Journal of Pharmaceutical Sciences. 2017; 106(12): 3515-23.
30. Ahad HA, Chinthaginjala H, Bhupalam P, Dasari RR, Rao BS, Tarun K. Designing of dexamethasone sodium phosphate ocular films for madras eye: In vitro and in vivo evaluation. Pakistan Journal of Pharmaceutical Sciences. 2021;34(2).
31. Santhi N, Rajendran S, Kumar NP, Sam SW, Narayanan RV. Simultaneous estimation of cefixime and ofloxacin in bulk and tablet dosage form. Asian Journal of Pharmaceutical Analysis. 2011; 1(3): 50-2.
32. Tanjin S, Islam F, Sultan MZ, Rahman A, Chowdhury SR, Sharmin T, et al. Development and validation of a simple RP-HPLC method for determination of naproxen in pharmaceutical dosage forms. Bangladesh Pharmaceutical Journal. 2013; 16(2): 137-41.
33. Kulkarni M, Dange P, Walode S. Development and Validation of Difference Spectrophotometric Method for Zotepine in Bulk and Tablet Dosage Form. Asian Journal of Pharmaceutical Analysis. 2013; 3(3): 105-7.
34. Patel JJ, Chorawala H, Dedania ZR, Vijendraswamy S. Development and Validation of UV Spectroscopic Method for Simultaneous Estimation of Doxofylline and Terbutaline Sulphate in Combined Dosage Form. Asian Journal of Pharmaceutical Analysis. 2015; 5(2): 74-8.
35. Muneer S, Ahad HA, Bonnoth CSK. A Novel Stability Indicating RP-HPLC Assay Method Development and Validation for the Quantification of Cyamemazine Tartrate in bulk and its Pharmaceutical Dosage Form. Asian Journal of Pharmaceutical Analysis. 2018; 8(3): 169-73.
36. Pawar PK, Katara R, Majumdar DK. Design and evaluation of moxifloxacin hydrochloride ocular insert. Acta Pharmaceutica. 2012; 62(1): 93-104.
37. Balguri SP, Adelli GR, Janga KY, Bhagav P, Majumdar S. Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol. International Journal of Pharmaceutics. 2017; 529(1-2): 32-43.
38. Khan N, Aqil M, Ameeduzzafar, Imam SS, Ali A. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization. Pharmaceutical Development and Technology. 2015; 20(6): 662-9.
39. Taghe S, Mirzaeei S, Alany RG, Nokhodchi A. Polymeric inserts containing Eudragit® L100 nanoparticle for improved ocular delivery of azithromycin. Biomedicines. 2020; 8(11): 466.
40. Mirzaeei S, Alizadeh M. Design and evaluation of soluble ocular insert for controlled release of chloramphenicol. Journal of Reports in Pharmaceutical Sciences. 2017; 6(2): 123-33.
41. El-Emam GA, Girgis GN, El-Sokkary MMA, El-Azeem Soliman OA, Abd El Gawad AEGH. Ocular inserts of voriconazole-loaded proniosomal gels: formulation, evaluation and microbiological studies. International Journal of Nanomedicine. 2020: 7825-40.
42. Grimaudo MA, Nicoli S, Santi P, Concheiro A, Alvarez-Lorenzo C. Cyclosporine-loaded cross-linked inserts of sodium hyaluronan and hydroxypropyl-β-cyclodextrin for ocular administration. Carbohydrate Polymers. 2018; 201: 308-16.
43. Mastiholimath V, Dandagi P, Gadad A, Mathews R, Kulkarni A. In vitro and in vivo evaluation of ranitidine hydrochloride ethyl cellulose floating microparticles. Journal of Microencapsulation. 2008; 25(5): 307-14.
44. Rahić O, Tucak A, Omerović N, Sirbubalo M, Hindija L, Hadžiabdić J, et al. Novel drug delivery systems fighting glaucoma: Formulation obstacles and solutions. Pharmaceutics. 2020; 13(1): 28.
45. Tambe S, Jain D, Rawat R, Mali S, Pagano MA, Brunati AM, et al. MeltSerts technology (brinzolamide ocular inserts via hot-melt extrusion): QbD-steered development, molecular dynamics, in vitro, ex vivo and in vivo studies. International Journal of Pharmaceutics. 2023; 648: 123579.
46. Franca JR, Foureaux G, Fuscaldi LL, Ribeiro TG, Rodrigues LB, Bravo R, et al. Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation. PloS one. 2014; 9(4): e95461.
47. Mathurm M, Gilhotra RM. Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E2-induced ocular inflammation. Drug Delivery. 2011; 18(1):54-64.
48. Ibrahim HK, El-Leithy IS, Makky AA. Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapy. Molecular Pharmaceutics. 2010; 7(2): 576-85.
49. Üstündağ-Okur N, Gökçe EH, Bozbıyık Dİ, Eğrilmez S, Ertan G, Özer Ö. Novel nanostructured lipid carrier-based inserts for controlled ocular drug delivery: evaluation of corneal bioavailability and treatment efficacy in bacterial keratitis. Expert Opinion on Drug Delivery. 2015; 12(11): 1791-807.
50. Singh V, Bushetti S, Raju SA, Ahmad R, Singh M, Ajmal M. Polymeric ocular hydrogels and ophthalmic inserts for controlled release of timolol maleate. Journal of Pharmacy and Bioallied Sciences. 2011; 3(2): 280.
51. Polat HK, Pehlivan SB, Özkul C, Çalamak S, Öztürk N, Aytekin E, et al. Development of besifloxacin HCl loaded nanofibrous ocular inserts for the treatment of bacterial keratitis: In vitro, ex vivo and in vivo evaluation. International Journal of Pharmaceutics. 2020; 585: 119552.
52. Shukr M. Formulation, in vitro and in vivo evaluation of lidocaine HCl ocular inserts for topical ocular anesthesia. Archives of Pharmacal Research. 2014; 37: 882-9.
53. Mirzaeei S, Taghe S, Alany RG, Nokhodchi A. Eudragit® L100/Polyvinyl Alcohol nanoparticles impregnated mucoadhesive films as ocular inserts for controlled delivery of erythromycin: development, characterization and in vivo evaluation. Biomedicines. 2022; 10(8):1917.
54. Gupta B, Mishra V, Gharat S, Momin M, Omri A. Cellulosic polymers for enhancing drug bioavailability in ocular drug delivery systems. Pharmaceuticals. 2021; 14(11): 1201.
55. Rathod LV, Kapadia R, Sawant KK. A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies. Materials Science and Engineering: C. 2017;71:529-40.
56. Bhattarai RS, Das A, Alzhrani RM, Kang D, Bhaduri SB, Boddu SH. Comparison of electrospun and solvent cast polylactic acid (PLA)/poly (vinyl alcohol)(PVA) inserts as potential ocular drug delivery vehicles. Materials Science and Engineering: C. 2017; 77: 895-903.
57. Umashankar C, Swamy N, Reddy N, Yadava M, Chandrasekhar M. Formulation and evaluation of novel ophthalmic drug delivery system of an anti-infective drug. Biomed. 2007; 2(2): 184-92.
58. Ozdemir S, Cakirli E, Surucu B, Ayguler CI, Uner B, Celebi ARC. Preparation and Characterization Studies of Dorzolamide-Loaded Ophthalmic Implants for Treating Glaucoma. Turkish Journal of Pharmaceutical Sciences. 2023;20(3):149-57.
59. RAO MV, Shyale S. Preparation and evaluation of ocular inserts containing norfloxacin. Turkish Journal of Medical Sciences. 2004; 34(4): 239-46.
60. Di Prima G, Licciardi M, Pavia FC, Monte AIL, Cavallaro G, Giammona G. Microfibrillar polymeric ocular inserts for triamcinolone acetonide delivery. International Journal of Pharmaceutics. 2019; 567: 118459.
61. Rao PCM, Nappinnai M, Raju S, Rao UMV, Reddy VB. Fluconazole ocular inserts: Formulation and in-vitro evaluation. Journal of Pharmaceutical Sciences and Research. 2010;2(6):344.
62. Pandey P, Panwar AS, Dwivedi P, Jain P, Agrawal A, Jain D. Design and evaluation of Ocular Inserts for controlled drug delivery of Acyclovir. International Journal of Pharmaceutical & Biological Archives. 2011; 2(4): 1106-10.
63. Jethava JK, Jethava GK. Design, formulation, and evaluation of novel sustain release bioadhesive in-situ gelling ocular inserts of ketorolac tromethamine. International Journal of Pharmaceutical Investigation. 2014; 4(4): 226.
64. MohammadSadeghi A, Farjadian F, Alipour S. Sustained release of linezolid in ocular insert based on lipophilic modified structure of sodium alginate. Iranian Journal of Basic Medical Sciences. 2021; 24(3): 331.
65. Sachdeva D, Bhandari A. Design, formulation, evaluation of levobunolol HCl ocular inserts. Journal of Pharmaceutical Sciences and Research. 2011; 3(12): 1625.
66. Gilhotra RM, Gilhotra N, Mishra D. Piroxicam bioadhesive ocular inserts: physicochemical characterization and evaluation in prostaglandin-induced inflammation. Current Eye Research. 2009; 34(12): 1065-73.
67. Girgis GN. Formulation and evaluation of Atorvastatin calcium-poly-ε-caprolactone nanoparticles loaded ocular inserts for sustained release and antiinflammatory efficacy. Current Pharmaceutical Biotechnology. 2020; 21(15): 1688-98.